Aurora Kinase B
This report aims to provide a comprehensive presentation of the global market for Aurora Kinase B ... Read More
Global Nuclear Receptor ROR Gamma Market Research Report 2024
1 Nuclear Receptor ROR Gamma Market Overview
1.1 Product Overview and Scope of Nuclear Receptor ROR Gamma
1.2 Nuclear Receptor ROR Gamma Segment by Type
1.2.1 Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2023-2029)
1.2.2 BBI-6000
1.2.3 GRC-39815Action
1.2.4 R&D Progress
1.2.5 GSK-2981278
1.2.6 IMU-366
1.2.7 INV-17
1.2.8 Others
1.3 Nuclear Receptor ROR Gamma Segment by Application
1.3.1 Global Nuclear Receptor ROR Gamma Market Value by Application: (2023-2029)
1.3.2 Chronic Obstructive Pulmonary Disease
1.3.3 Asthma
1.3.4 Axial Spondyloarthritis
1.3.5 Breast Cancer
1.3.6 Others
1.4 Global Nuclear Receptor ROR Gamma Market Size Estimates and Forecasts
1.4.1 Global Nuclear Receptor ROR Gamma Revenue 2018-2029
1.4.2 Global Nuclear Receptor ROR Gamma Sales 2018-2029
1.4.3 Global Nuclear Receptor ROR Gamma Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Nuclear Receptor ROR Gamma Market Competition by Manufacturers
2.1 Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2018-2023)
2.2 Global Nuclear Receptor ROR Gamma Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Nuclear Receptor ROR Gamma Average Price by Manufacturers (2018-2023)
2.4 Global Nuclear Receptor ROR Gamma Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application
2.7 Nuclear Receptor ROR Gamma Market Competitive Situation and Trends
2.7.1 Nuclear Receptor ROR Gamma Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Nuclear Receptor ROR Gamma Players Market Share by Revenue
2.7.3 Global Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Nuclear Receptor ROR Gamma Retrospective Market Scenario by Region
3.1 Global Nuclear Receptor ROR Gamma Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Nuclear Receptor ROR Gamma Global Nuclear Receptor ROR Gamma Sales by Region: 2018-2029
3.2.1 Global Nuclear Receptor ROR Gamma Sales by Region: 2018-2023
3.2.2 Global Nuclear Receptor ROR Gamma Sales by Region: 2024-2029
3.3 Global Nuclear Receptor ROR Gamma Global Nuclear Receptor ROR Gamma Revenue by Region: 2018-2029
3.3.1 Global Nuclear Receptor ROR Gamma Revenue by Region: 2018-2023
3.3.2 Global Nuclear Receptor ROR Gamma Revenue by Region: 2024-2029
3.4 North America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.4.1 North America Nuclear Receptor ROR Gamma Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Nuclear Receptor ROR Gamma Sales by Country (2018-2029)
3.4.3 North America Nuclear Receptor ROR Gamma Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.5.1 Europe Nuclear Receptor ROR Gamma Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Nuclear Receptor ROR Gamma Sales by Country (2018-2029)
3.5.3 Europe Nuclear Receptor ROR Gamma Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.6.1 Asia Pacific Nuclear Receptor ROR Gamma Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Nuclear Receptor ROR Gamma Sales by Country (2018-2029)
3.6.3 Asia Pacific Nuclear Receptor ROR Gamma Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.7.1 Latin America Nuclear Receptor ROR Gamma Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Nuclear Receptor ROR Gamma Sales by Country (2018-2029)
3.7.3 Latin America Nuclear Receptor ROR Gamma Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Nuclear Receptor ROR Gamma Market Facts & Figures by Country
3.8.1 Middle East and Africa Nuclear Receptor ROR Gamma Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Nuclear Receptor ROR Gamma Sales by Country (2018-2029)
3.8.3 Middle East and Africa Nuclear Receptor ROR Gamma Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Nuclear Receptor ROR Gamma Sales by Type (2018-2029)
4.1.1 Global Nuclear Receptor ROR Gamma Sales by Type (2018-2023)
4.1.2 Global Nuclear Receptor ROR Gamma Sales by Type (2024-2029)
4.1.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2018-2029)
4.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2018-2029)
4.2.1 Global Nuclear Receptor ROR Gamma Revenue by Type (2018-2023)
4.2.2 Global Nuclear Receptor ROR Gamma Revenue by Type (2024-2029)
4.2.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2018-2029)
4.3 Global Nuclear Receptor ROR Gamma Price by Type (2018-2029)
5 Segment by Application
5.1 Global Nuclear Receptor ROR Gamma Sales by Application (2018-2029)
5.1.1 Global Nuclear Receptor ROR Gamma Sales by Application (2018-2023)
5.1.2 Global Nuclear Receptor ROR Gamma Sales by Application (2024-2029)
5.1.3 Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2018-2029)
5.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2018-2029)
5.2.1 Global Nuclear Receptor ROR Gamma Revenue by Application (2018-2023)
5.2.2 Global Nuclear Receptor ROR Gamma Revenue by Application (2024-2029)
5.2.3 Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2018-2029)
5.3 Global Nuclear Receptor ROR Gamma Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Genfit SA
6.1.1 Genfit SA Corporation Information
6.1.2 Genfit SA Description and Business Overview
6.1.3 Genfit SA Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Genfit SA Nuclear Receptor ROR Gamma Product Portfolio
6.1.5 Genfit SA Recent Developments/Updates
6.2 GlaxoSmithKline Plc
6.2.1 GlaxoSmithKline Plc Corporation Information
6.2.2 GlaxoSmithKline Plc Description and Business Overview
6.2.3 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.2.4 GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product Portfolio
6.2.5 GlaxoSmithKline Plc Recent Developments/Updates
6.3 Aurigene Discovery Technologies
6.3.1 Aurigene Discovery Technologies Corporation Information
6.3.2 Aurigene Discovery Technologies Description and Business Overview
6.3.3 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product Portfolio
6.3.5 Aurigene Discovery Technologies Recent Developments/Updates
6.4 Beijing Hanmi Pharmaceutical
6.4.1 Beijing Hanmi Pharmaceutical Corporation Information
6.4.2 Beijing Hanmi Pharmaceutical Description and Business Overview
6.4.3 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product Portfolio
6.4.5 Beijing Hanmi Pharmaceutical Recent Developments/Updates
6.5 Biogen Inc
6.5.1 Biogen Inc Corporation Information
6.5.2 Biogen Inc Description and Business Overview
6.5.3 Biogen Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Biogen Inc Nuclear Receptor ROR Gamma Product Portfolio
6.5.5 Biogen Inc Recent Developments/Updates
6.6 AbbVie Inc
6.6.1 AbbVie Inc Corporation Information
6.6.2 AbbVie Inc Description and Business Overview
6.6.3 AbbVie Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.6.4 AbbVie Inc Nuclear Receptor ROR Gamma Product Portfolio
6.6.5 AbbVie Inc Recent Developments/Updates
6.7 Eurofins Advinus
6.6.1 Eurofins Advinus Corporation Information
6.6.2 Eurofins Advinus Description and Business Overview
6.6.3 Eurofins Advinus Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Eurofins Advinus Nuclear Receptor ROR Gamma Product Portfolio
6.7.5 Eurofins Advinus Recent Developments/Updates
6.8 Brickell Biotech Inc
6.8.1 Brickell Biotech Inc Corporation Information
6.8.2 Brickell Biotech Inc Description and Business Overview
6.8.3 Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Brickell Biotech Inc Nuclear Receptor ROR Gamma Product Portfolio
6.8.5 Brickell Biotech Inc Recent Developments/Updates
6.9 Pfizer Inc
6.9.1 Pfizer Inc Corporation Information
6.9.2 Pfizer Inc Description and Business Overview
6.9.3 Pfizer Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Pfizer Inc Nuclear Receptor ROR Gamma Product Portfolio
6.9.5 Pfizer Inc Recent Developments/Updates
6.10 Phenex Pharmaceuticals AG
6.10.1 Phenex Pharmaceuticals AG Corporation Information
6.10.2 Phenex Pharmaceuticals AG Description and Business Overview
6.10.3 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product Portfolio
6.10.5 Phenex Pharmaceuticals AG Recent Developments/Updates
6.11 Reata Pharmaceuticals Inc
6.11.1 Reata Pharmaceuticals Inc Corporation Information
6.11.2 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Description and Business Overview
6.11.3 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product Portfolio
6.11.5 Reata Pharmaceuticals Inc Recent Developments/Updates
6.12 Bristol-Myers Squibb Company
6.12.1 Bristol-Myers Squibb Company Corporation Information
6.12.2 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Description and Business Overview
6.12.3 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product Portfolio
6.12.5 Bristol-Myers Squibb Company Recent Developments/Updates
6.13 Celgene Corp
6.13.1 Celgene Corp Corporation Information
6.13.2 Celgene Corp Nuclear Receptor ROR Gamma Description and Business Overview
6.13.3 Celgene Corp Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Celgene Corp Nuclear Receptor ROR Gamma Product Portfolio
6.13.5 Celgene Corp Recent Developments/Updates
6.14 Eli Lilly
6.14.1 Eli Lilly Corporation Information
6.14.2 Eli Lilly Nuclear Receptor ROR Gamma Description and Business Overview
6.14.3 Eli Lilly Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Eli Lilly Nuclear Receptor ROR Gamma Product Portfolio
6.14.5 Eli Lilly Recent Developments/Updates
6.15 Glenmark Pharmaceuticals
6.15.1 Glenmark Pharmaceuticals Corporation Information
6.15.2 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Description and Business Overview
6.15.3 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product Portfolio
6.15.5 Glenmark Pharmaceuticals Recent Developments/Updates
6.16 Lead Pharma Holding BV
6.16.1 Lead Pharma Holding BV Corporation Information
6.16.2 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Description and Business Overview
6.16.3 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product Portfolio
6.16.5 Lead Pharma Holding BV Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Nuclear Receptor ROR Gamma Industry Chain Analysis
7.2 Nuclear Receptor ROR Gamma Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Nuclear Receptor ROR Gamma Production Mode & Process
7.4 Nuclear Receptor ROR Gamma Sales and Marketing
7.4.1 Nuclear Receptor ROR Gamma Sales Channels
7.4.2 Nuclear Receptor ROR Gamma Distributors
7.5 Nuclear Receptor ROR Gamma Customers
8 Nuclear Receptor ROR Gamma Market Dynamics
8.1 Nuclear Receptor ROR Gamma Industry Trends
8.2 Nuclear Receptor ROR Gamma Market Drivers
8.3 Nuclear Receptor ROR Gamma Market Challenges
8.4 Nuclear Receptor ROR Gamma Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Nuclear Receptor ROR Gamma Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Nuclear Receptor ROR Gamma Market Competitive Situation by Manufacturers in 2022
Table 4. Global Nuclear Receptor ROR Gamma Sales (K Pcs) of Key Manufacturers (2018-2023)
Table 5. Global Nuclear Receptor ROR Gamma Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Nuclear Receptor ROR Gamma Average Price (USD/Pcs) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Nuclear Receptor ROR Gamma, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Product Type & Application
Table 12. Global Key Manufacturers of Nuclear Receptor ROR Gamma, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Nuclear Receptor ROR Gamma by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nuclear Receptor ROR Gamma as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Nuclear Receptor ROR Gamma Sales by Region (2018-2023) & (K Pcs)
Table 18. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2018-2023)
Table 19. Global Nuclear Receptor ROR Gamma Sales by Region (2024-2029) & (K Pcs)
Table 20. Global Nuclear Receptor ROR Gamma Sales Market Share by Region (2024-2029)
Table 21. Global Nuclear Receptor ROR Gamma Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2018-2023)
Table 23. Global Nuclear Receptor ROR Gamma Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Nuclear Receptor ROR Gamma Revenue Market Share by Region (2024-2029)
Table 25. North America Nuclear Receptor ROR Gamma Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Nuclear Receptor ROR Gamma Sales by Country (2018-2023) & (K Pcs)
Table 27. North America Nuclear Receptor ROR Gamma Sales by Country (2024-2029) & (K Pcs)
Table 28. North America Nuclear Receptor ROR Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Nuclear Receptor ROR Gamma Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Nuclear Receptor ROR Gamma Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Nuclear Receptor ROR Gamma Sales by Country (2018-2023) & (K Pcs)
Table 32. Europe Nuclear Receptor ROR Gamma Sales by Country (2024-2029) & (K Pcs)
Table 33. Europe Nuclear Receptor ROR Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Nuclear Receptor ROR Gamma Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2018-2023) & (K Pcs)
Table 37. Asia Pacific Nuclear Receptor ROR Gamma Sales by Region (2024-2029) & (K Pcs)
Table 38. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Nuclear Receptor ROR Gamma Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Nuclear Receptor ROR Gamma Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Nuclear Receptor ROR Gamma Sales by Country (2018-2023) & (K Pcs)
Table 42. Latin America Nuclear Receptor ROR Gamma Sales by Country (2024-2029) & (K Pcs)
Table 43. Latin America Nuclear Receptor ROR Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Nuclear Receptor ROR Gamma Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Country (2018-2023) & (K Pcs)
Table 47. Middle East & Africa Nuclear Receptor ROR Gamma Sales by Country (2024-2029) & (K Pcs)
Table 48. Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Nuclear Receptor ROR Gamma Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2018-2023)
Table 51. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Type (2024-2029)
Table 52. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2018-2023)
Table 53. Global Nuclear Receptor ROR Gamma Sales Market Share by Type (2024-2029)
Table 54. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2018-2023)
Table 57. Global Nuclear Receptor ROR Gamma Revenue Market Share by Type (2024-2029)
Table 58. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2018-2023)
Table 59. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2024-2029)
Table 60. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2018-2023)
Table 61. Global Nuclear Receptor ROR Gamma Sales (K Pcs) by Application (2024-2029)
Table 62. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2018-2023)
Table 63. Global Nuclear Receptor ROR Gamma Sales Market Share by Application (2024-2029)
Table 64. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Nuclear Receptor ROR Gamma Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2018-2023)
Table 67. Global Nuclear Receptor ROR Gamma Revenue Market Share by Application (2024-2029)
Table 68. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2018-2023)
Table 69. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2024-2029)
Table 70. Genfit SA Corporation Information
Table 71. Genfit SA Description and Business Overview
Table 72. Genfit SA Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 73. Genfit SA Nuclear Receptor ROR Gamma Product
Table 74. Genfit SA Recent Developments/Updates
Table 75. GlaxoSmithKline Plc Corporation Information
Table 76. GlaxoSmithKline Plc Description and Business Overview
Table 77. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 78. GlaxoSmithKline Plc Nuclear Receptor ROR Gamma Product
Table 79. GlaxoSmithKline Plc Recent Developments/Updates
Table 80. Aurigene Discovery Technologies Corporation Information
Table 81. Aurigene Discovery Technologies Description and Business Overview
Table 82. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 83. Aurigene Discovery Technologies Nuclear Receptor ROR Gamma Product
Table 84. Aurigene Discovery Technologies Recent Developments/Updates
Table 85. Beijing Hanmi Pharmaceutical Corporation Information
Table 86. Beijing Hanmi Pharmaceutical Description and Business Overview
Table 87. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 88. Beijing Hanmi Pharmaceutical Nuclear Receptor ROR Gamma Product
Table 89. Beijing Hanmi Pharmaceutical Recent Developments/Updates
Table 90. Biogen Inc Corporation Information
Table 91. Biogen Inc Description and Business Overview
Table 92. Biogen Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 93. Biogen Inc Nuclear Receptor ROR Gamma Product
Table 94. Biogen Inc Recent Developments/Updates
Table 95. AbbVie Inc Corporation Information
Table 96. AbbVie Inc Description and Business Overview
Table 97. AbbVie Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 98. AbbVie Inc Nuclear Receptor ROR Gamma Product
Table 99. AbbVie Inc Recent Developments/Updates
Table 100. Eurofins Advinus Corporation Information
Table 101. Eurofins Advinus Description and Business Overview
Table 102. Eurofins Advinus Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 103. Eurofins Advinus Nuclear Receptor ROR Gamma Product
Table 104. Eurofins Advinus Recent Developments/Updates
Table 105. Brickell Biotech Inc Corporation Information
Table 106. Brickell Biotech Inc Description and Business Overview
Table 107. Brickell Biotech Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 108. Brickell Biotech Inc Nuclear Receptor ROR Gamma Product
Table 109. Brickell Biotech Inc Recent Developments/Updates
Table 110. Pfizer Inc Corporation Information
Table 111. Pfizer Inc Description and Business Overview
Table 112. Pfizer Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 113. Pfizer Inc Nuclear Receptor ROR Gamma Product
Table 114. Pfizer Inc Recent Developments/Updates
Table 115. Phenex Pharmaceuticals AG Corporation Information
Table 116. Phenex Pharmaceuticals AG Description and Business Overview
Table 117. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 118. Phenex Pharmaceuticals AG Nuclear Receptor ROR Gamma Product
Table 119. Phenex Pharmaceuticals AG Recent Developments/Updates
Table 120. Reata Pharmaceuticals Inc Corporation Information
Table 121. Reata Pharmaceuticals Inc Description and Business Overview
Table 122. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 123. Reata Pharmaceuticals Inc Nuclear Receptor ROR Gamma Product
Table 124. Reata Pharmaceuticals Inc Recent Developments/Updates
Table 125. Bristol-Myers Squibb Company Corporation Information
Table 126. Bristol-Myers Squibb Company Description and Business Overview
Table 127. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 128. Bristol-Myers Squibb Company Nuclear Receptor ROR Gamma Product
Table 129. Bristol-Myers Squibb Company Recent Developments/Updates
Table 130. Celgene Corp Corporation Information
Table 131. Celgene Corp Description and Business Overview
Table 132. Celgene Corp Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 133. Celgene Corp Nuclear Receptor ROR Gamma Product
Table 134. Celgene Corp Recent Developments/Updates
Table 135. Eli Lilly Corporation Information
Table 136. Eli Lilly Description and Business Overview
Table 137. Eli Lilly Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 138. Eli Lilly Nuclear Receptor ROR Gamma Product
Table 139. Eli Lilly Recent Developments/Updates
Table 140. Glenmark Pharmaceuticals Corporation Information
Table 141. Glenmark Pharmaceuticals Description and Business Overview
Table 142. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 143. Glenmark Pharmaceuticals Nuclear Receptor ROR Gamma Product
Table 144. Glenmark Pharmaceuticals Recent Developments/Updates
Table 145. Lead Pharma Holding BV Corporation Information
Table 146. Lead Pharma Holding BV Description and Business Overview
Table 147. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2023)
Table 148. Lead Pharma Holding BV Nuclear Receptor ROR Gamma Product
Table 149. Lead Pharma Holding BV Recent Developments/Updates
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Nuclear Receptor ROR Gamma Distributors List
Table 153. Nuclear Receptor ROR Gamma Customers List
Table 154. Nuclear Receptor ROR Gamma Market Trends
Table 155. Nuclear Receptor ROR Gamma Market Drivers
Table 156. Nuclear Receptor ROR Gamma Market Challenges
Table 157. Nuclear Receptor ROR Gamma Market Restraints
Table 158. Research Programs/Design for This Report
Table 159. Key Data Information from Secondary Sources
Table 160. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Nuclear Receptor ROR Gamma
Figure 2. Global Nuclear Receptor ROR Gamma Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Nuclear Receptor ROR Gamma Market Share by Type in 2022 & 2029
Figure 4. BBI-6000 Product Picture
Figure 5. GRC-39815Action Product Picture
Figure 6. R&D Progress Product Picture
Figure 7. GSK-2981278 Product Picture
Figure 8. IMU-366 Product Picture
Figure 9. INV-17 Product Picture
Figure 10. Others Product Picture
Figure 11. Global Nuclear Receptor ROR Gamma Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 12. Global Nuclear Receptor ROR Gamma Market Share by Application in 2022 & 2029
Figure 13. Chronic Obstructive Pulmonary Disease
Figure 14. Asthma
Figure 15. Axial Spondyloarthritis
Figure 16. Breast Cancer
Figure 17. Others
Figure 18. Global Nuclear Receptor ROR Gamma Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 19. Global Nuclear Receptor ROR Gamma Market Size (2018-2029) & (US$ Million)
Figure 20. Global Nuclear Receptor ROR Gamma Sales (2018-2029) & (K Pcs)
Figure 21. Global Nuclear Receptor ROR Gamma Average Price (USD/Pcs) & (2018-2029)
Figure 22. Nuclear Receptor ROR Gamma Report Years Considered
Figure 23. Nuclear Receptor ROR Gamma Sales Share by Manufacturers in 2022
Figure 24. Global Nuclear Receptor ROR Gamma Revenue Share by Manufacturers in 2022
Figure 25. The Global 5 and 10 Largest Nuclear Receptor ROR Gamma Players: Market Share by Revenue in 2022
Figure 26. Nuclear Receptor ROR Gamma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 27. Global Nuclear Receptor ROR Gamma Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 28. North America Nuclear Receptor ROR Gamma Sales Market Share by Country (2018-2029)
Figure 29. North America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2018-2029)
Figure 30. U.S. Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Canada Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Europe Nuclear Receptor ROR Gamma Sales Market Share by Country (2018-2029)
Figure 33. Europe Nuclear Receptor ROR Gamma Revenue Market Share by Country (2018-2029)
Figure 34. Germany Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. France Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. U.K. Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. Italy Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Russia Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Asia Pacific Nuclear Receptor ROR Gamma Sales Market Share by Region (2018-2029)
Figure 40. Asia Pacific Nuclear Receptor ROR Gamma Revenue Market Share by Region (2018-2029)
Figure 41. China Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Japan Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. South Korea Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. India Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 45. Australia Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 46. Taiwan Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Indonesia Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Thailand Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Malaysia Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Philippines Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 51. Latin America Nuclear Receptor ROR Gamma Sales Market Share by Country (2018-2029)
Figure 52. Latin America Nuclear Receptor ROR Gamma Revenue Market Share by Country (2018-2029)
Figure 53. Mexico Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Brazil Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Argentina Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 56. Middle East & Africa Nuclear Receptor ROR Gamma Sales Market Share by Country (2018-2029)
Figure 57. Middle East & Africa Nuclear Receptor ROR Gamma Revenue Market Share by Country (2018-2029)
Figure 58. Turkey Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 59. Saudi Arabia Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 60. UAE Nuclear Receptor ROR Gamma Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 61. Global Sales Market Share of Nuclear Receptor ROR Gamma by Type (2018-2029)
Figure 62. Global Revenue Market Share of Nuclear Receptor ROR Gamma by Type (2018-2029)
Figure 63. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Type (2018-2029)
Figure 64. Global Sales Market Share of Nuclear Receptor ROR Gamma by Application (2018-2029)
Figure 65. Global Revenue Market Share of Nuclear Receptor ROR Gamma by Application (2018-2029)
Figure 66. Global Nuclear Receptor ROR Gamma Price (USD/Pcs) by Application (2018-2029)
Figure 67. Nuclear Receptor ROR Gamma Value Chain
Figure 68. Nuclear Receptor ROR Gamma Production Process
Figure 69. Channels of Distribution (Direct Vs Distribution)
Figure 70. Distributors Profiles
Figure 71. Bottom-up and Top-down Approaches for This Report
Figure 72. Data Triangulation
Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Genfit SA GlaxoSmithKline Plc Aurigene Discovery Technologies Beijing Hanmi Pharmaceutical Biogen Inc AbbVie Inc Eurofins Advinus Brickell Biotech Inc Pfizer Inc Phenex Pharmaceuticals AG Reata Pharmaceuticals Inc Bristol-Myers Squibb Company Celgene Corp Eli Lilly Glenmark Pharmaceuticals Lead Pharma Holding BV